🇺🇸 Ascendis Pharma A/SASND
Get Ascendis Pharma A/S filings on Telegram the moment they are published.
Follow Ascendis Pharma A/S on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 6-K — Foreign issuer report
Overview: The CHMP adopted a positive opinion recommending marketing authorization for TransCon CNP to treat achondroplasia in children, with an EC decision expected Q4 2026.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest